- Home
- INO vs GNTA Comparison
INO vs GNTA Comparison
Compare INO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- GNTA
- Stock Information
- Founded
- INO 1979
- GNTA 2014
- Country
- INO United States
- GNTA Italy
- Employees
- INO N/A
- GNTA N/A
- Industry
- INO Medical/Dental Instruments
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INO Health Care
- GNTA Health Care
- Exchange
- INO Nasdaq
- GNTA Nasdaq
- Market Cap
- INO 110.7M
- GNTA 96.9M
- IPO Year
- INO 1998
- GNTA 2021
- Fundamental
- Price
- INO $4.30
- GNTA $5.06
- Analyst Decision
- INO Buy
- GNTA Strong Buy
- Analyst Count
- INO 6
- GNTA 1
- Target Price
- INO $21.00
- GNTA $25.00
- AVG Volume (30 Days)
- INO 320.4K
- GNTA 8.6K
- Earning Date
- INO 11-14-2024
- GNTA 01-01-0001
- Dividend Yield
- INO N/A
- GNTA N/A
- EPS Growth
- INO N/A
- GNTA N/A
- EPS
- INO N/A
- GNTA N/A
- Revenue
- INO $203,413.00
- GNTA N/A
- Revenue This Year
- INO N/A
- GNTA N/A
- Revenue Next Year
- INO N/A
- GNTA N/A
- P/E Ratio
- INO N/A
- GNTA N/A
- Revenue Growth
- INO N/A
- GNTA N/A
- 52 Week Low
- INO $4.20
- GNTA $2.20
- 52 Week High
- INO $14.75
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- INO 23.84
- GNTA 50.84
- Support Level
- INO $5.25
- GNTA $4.61
- Resistance Level
- INO $5.60
- GNTA $5.44
- Average True Range (ATR)
- INO 0.27
- GNTA 0.46
- MACD
- INO -0.08
- GNTA -0.05
- Stochastic Oscillator
- INO 1.11
- GNTA 56.54
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.